Trump says he would take COVID-19 vaccine first if asked
Jul 24 2020
This content is shared here because the topic may interest Snopes readers; it does not, however, represent the work of Snopes fact-checkers or editors.
Pfizer has struck a almost $2 billion deal with the United States government to supply 100 million doses of a vaccine for COVID-19.
After receiving the first 100 million doses, the United States government will pay BioNTech and Pfizer $1.95 billion.
"But there are a lot of global collaborations and efforts being put in to see whether we can see an effective, usable, deployable vaccine for the human race around the world".
Studies published Monday in British medical journal The Lancet found two vaccine candidates were safe and produced an immune response in Phase 2 trials: the Oxford vaccine and another Chinese-made vaccine, developed by pharmaceutical firm CanSino Biologics and the Beijing Institute of Biotechnology.
He estimates it could take less than three months before Africa accesses the Covid-19 vaccine once it's available, and that is perhaps because there are a lot of partnerships in place.
The agreement is part of President Donald Trump'sOperation Warp Speed vaccine program, under which multiple COVID-19 vaccines are being developed simultaneously.
If the ongoing studies are successful, and the vaccine candidate receives regulatory approval, the companies now expect to manufacture up to 100 million doses by December and potentially more than 1.3 billion doses by the end of 2021.
Once approved, it will be available to Americans for free, the release says.
Moderna's vaccine is similar to the Pfizer one in that it also uses a messenger RNA platform.
More than 150 potential vaccines are in development across the world, with two dozen already in human trials.
How this could play out: If the vaccine is successful and receives EUA or licensure, nationwide delivery would begin in the fourth quarter of 2020. A few other vaccines have begun smaller late-stage studies in other countries, and in the USA a series of huge studies are planned to begin each month through fall in hopes of, eventually, having several vaccines to use.
The subcommittee also stressed the importance of worldwide distribution of any vaccines proven effective against the coronavirus to ensure global health. "He wanted to get the vaccine first", Trump told Siegel. "We do not expect to be able to accelerate the safety assessment", Gerberding said. But we're doing very well with remdesivir and other things. I think we're optimistic.
The Economist reported recently that it might be clear by the end of next month, August, whether or not the vaccine is effective.
The Oxford vaccine had prompted an antibody and a T-cell response - both of which may be important in the protection against COVID-19. Since the virus' emergence and its disease - COVID-19 - the race has been on to find a way to stop it in its tracks.
There are now close to 200 vaccines for Covid-19 under development across the world, but Oxford University in the United Kingdom is leading the race to develop the world's first vaccine against the virus.